정책동향
Technologies for Commercialization
- 등록일2011-06-01
- 조회수5265
- 분류정책동향 > 기타 > 기타
-
자료발간일
2011-04-26
-
출처
Indian Council of Medical Research,
-
원문링크
-
키워드
#인도#Indian
- 첨부파일
Technologies_for_Commercialization_2011.pdf
Technologies for Commercialization
National Institute of Virology (NIV),Pune
Japanese Encephalitis Vaccine
Product/Process: Chimeric peptide vaccine candidate against Japanese Encephalitis virus.
Application/Uses: Japanese encephalitis virus is endemic in many areas of India.
Chimeric peptide sequences can be incorporated in the future vaccines.
Salient Technical Features: Using combination of bioinformatic tools and immunological studies, peptide sequences inducing neutralizing antibodies and T helper activity in mice were identified. Chimeric peptides incorporating both these epitopes showed induction of immunity against JE virus and partial protection from lethal challenge in mouse model.
Scale of Development: The project was a collaborative effort between National Institute of Virology, Pune, and Bioinformatics Centre, University of Pune, with funding from Department of Biotechnology, New Delhi. It is developed up to laboratory scale.
Status of Commercialization: Four international patents were filed in USA (Application no. 10/250,468), Korea and Japan and Philippines and one national phase appllication was filed in India based on PCT application (Application no.
PCT/INO2/0003). Negotiation are in progress with Hyderabad based Company M/s Bharat Biotech India Ltd. for commercializing this technology.
.......(계속)
☞ 자세한 내용은 첨부파일을 참고하시기 바랍니다.
지식